Skip to main content
Profound Medical Corp. logo

Profound Medical Corp. — Investor Relations & Filings

Ticker · PROF TSX Manufacturing
Open in API
Filings indexed 659 across all filing types
Latest filing 2025-03-08 Interim / Quarterly Rep…
Country CA Canada
Listing TSX PROF

About Profound Medical Corp.

https://profoundmedical.com/

Profound Medical Corp. is a commercial-stage medical technology company specializing in incision-free ablative therapies. Its core product is TULSA-PRO®, a therapeutic platform designed for the treatment of localized prostate cancer, radiorecurrent prostate cancer, and benign prostatic hyperplasia (BPH). TULSA-PRO utilizes a robotically controlled, transurethral ultrasound ablation procedure guided by real-time Magnetic Resonance (MR) imaging. This system employs closed-loop temperature feedback to ensure precise and customizable tissue ablation, prioritizing patient safety and minimizing complications. The technology merges MR imaging, thermal ultrasound, and robotics to offer a durable and accurate treatment delivery method.

Recent filings

Filing Released Lang Actions
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive set of unaudited condensed consolidated financial statements for Profound Medical Corp. for the quarter ended June 30, 2024. It includes balance sheets, statements of operations, statements of shareholders' equity, statements of cash flows, and detailed notes to the financial statements. As it contains substantive financial data for an interim period (quarterly), it is classified as an Interim/Quarterly Report (IR). H1 2024
2025-03-08 English
52-109F2R - Certification of refiled interim filings - CFO (E).pdf
Regulatory Filings Classification · 85% confidence The document is a Form 52-109F2R “Certification of Refiled Interim Filings” under Canadian securities rules. It is a regulatory certification statement by the CFO about interim financial statements and MD&A, not the interim report itself or an earnings summary. It does not present full financial results, nor is it a dividend, proxy, or management discussion. As a standalone compliance certificate, it best fits the fallback “Regulatory Filings” category.
2025-03-08 English
52-109F2R - Certification of refiled interim filings - CEO (E).pdf
Regulatory Filings Classification · 75% confidence The document is a CEO’s certification of refiled interim financial statements under Canadian NI 52-109. It is not the interim financial report itself (so not an IR), nor an audit opinion (AR), earnings release, MD&A, or proxy material. It serves as a regulatory attestation filing. Since it does not match any specific category, it falls under the general Regulatory Filings category (RNS).
2025-03-08 English
Interim MD&A - English.pdf
Management Reports Classification · 95% confidence The document is titled “Management’s Discussion and Analysis” (MD&A) for the three months ended March 31, 2024 and 2023, providing a detailed narrative of financial results, business trends, restatements, forward‐looking statements, and an overview of operations. It is clearly the management’s detailed explanation of interim results, rather than a full annual report or a simple regulatory notice. Under the provided taxonomy, this aligns with “Management Reports” (Code: MDA).
2025-03-08 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive set of unaudited condensed consolidated financial statements for Profound Medical Corp. for the quarter ended March 31, 2024. It includes balance sheets, statements of operations, statements of shareholders' equity, statements of cash flows, and detailed notes to the financial statements. This content constitutes a formal quarterly financial report, which fits the definition of an Interim/Quarterly Report (IR). Q1 2024
2025-03-08 English
News release - English.pdf
Regulatory Filings
2025-03-06 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.